137 related articles for article (PubMed ID: 30968417)
1. Scale-up of hepatitis C treatment in prisons is key to national elimination.
Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
[No Abstract] [Full Text] [Related]
2. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
[TBL] [Abstract][Full Text] [Related]
3. Enhancing hepatitis C treatment in the custodial setting: a national roadmap.
Mina MM; Clark PJ; Beasley HM; Herawati L; Butler TG; Lloyd AR
Med J Aust; 2014 Jan; 200(1):15-6. PubMed ID: 24438398
[No Abstract] [Full Text] [Related]
4. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
5. People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving.
Dore GJ; Trooskin S
N Engl J Med; 2020 Aug; 383(7):608-611. PubMed ID: 32786185
[No Abstract] [Full Text] [Related]
6. Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?
Marco A; Guerrero RA; Turu E; Gallego C; Teixidó N; Sastre A; Caylà JA;
Rev Esp Sanid Penit; 2019; 21(1):38-41. PubMed ID: 31498858
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis C and HIV in Spanish prisons].
Soriano V; González-Lahoz J
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):51-2. PubMed ID: 15743572
[No Abstract] [Full Text] [Related]
8. Elimination of Hepatitis C Virus in Australia: Laying the Foundation.
Dore GJ; Hajarizadeh B
Infect Dis Clin North Am; 2018 Jun; 32(2):269-279. PubMed ID: 29778255
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.
Bate JP; Colman AJ; Frost PJ; Shaw DR; Harley HA
J Gastroenterol Hepatol; 2010 Jul; 25(7):1276-80. PubMed ID: 20594255
[TBL] [Abstract][Full Text] [Related]
10. [Expert recommendations for the diagnosis and treatment of chronic hepatitis C infection in the prison setting].
Saiz de la Hoya-Zamácola P; Marco-Mouriño A; Clemente-Ricote G; Portilla-Sogorb J; Boix-Martínez V; Núñez-Martínez O; Reus-Bañuls S; Teixidó i Pérez N
Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):568-75. PubMed ID: 17125677
[TBL] [Abstract][Full Text] [Related]
11. Good results of chronic HCV management in a single centre prison population.
Sherfi H; Needs S; George K; Neale J
Clin Med (Lond); 2016 Jun; 16 Suppl 3(Suppl 3):s15. PubMed ID: 27252317
[No Abstract] [Full Text] [Related]
12. [Is hepatitis C important for drug addicts?].
Aavitsland P
Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
[No Abstract] [Full Text] [Related]
13. A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.
Fleurence RL; Collins FS
JAMA; 2023 Apr; 329(15):1251-1252. PubMed ID: 36892976
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C in active drug users.
Davis GL; Rodrigue JR
N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
[No Abstract] [Full Text] [Related]
15. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
Gazdag G; Horvath G; Szabo O; Ungvari GS
Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
[TBL] [Abstract][Full Text] [Related]
16. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
[TBL] [Abstract][Full Text] [Related]
17. Eradicating hepatitis C from the New South Wales prison system.
Blogg J; Wood J; McGrath C; Lobo C
Med J Aust; 2018 Apr; 208(6):276. PubMed ID: 29614945
[No Abstract] [Full Text] [Related]
18. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
Martinello M; Dore GJ; Matthews GV; Grebely J
Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
[TBL] [Abstract][Full Text] [Related]
19. Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.
Kikvidze T; Luhmann N; Avril E; Butsashvili M; Labartkava K; Etienne A; Le Pluart D; Inaridze I; Gamezardashvili A; Kharshiladze D; Bouscaillou J
Int J Drug Policy; 2018 Feb; 52():16-19. PubMed ID: 29227878
[No Abstract] [Full Text] [Related]
20. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Remy AJ; Wenger H; Bouchkira H
Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
